| Authors: |
Gallon R; Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK. richard.gallon@newcastle.ac.uk., McCormick L; Genomic Diagnostics Laboratory, Manchester Centre for Genomic Medicine, St Mary's Hospital, Manchester, UK., Saetta A; 1st Department of Pathology, Faculty of Medicine, National and Kapodistrian University of Athens, Athens, Greece., Albuquerque C; Unidade de Investigação em Patobiologia Molecular, Instituto Português de Oncologia de Lisboa Francisco Gentil, E.P.E., Lisboa, Portugal., Butler S; West Midlands Regional Genetics Laboratory, Birmingham Women's Hospital, Birmingham, UK., Cranston T; Oxford Medical Genetics Laboratories, Oxford University Hospitals NHS Trust, Oxford, UK., Field J; East Midlands Regional Molecular Genetics Service, City Hospital Campus, Nottingham University Hospitals NHS Trust, Nottingham, UK., McAnulty C; Northern Genetics Service, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK., Silva P; Unidade de Investigação em Patobiologia Molecular, Instituto Português de Oncologia de Lisboa Francisco Gentil, E.P.E., Lisboa, Portugal., Cheetham M; EMQN, Manchester, UK., Sheils K; EMQN, Manchester, UK. katie.sheils@emqn.org., Burghel GJ; Genomic Diagnostics Laboratory, Manchester Centre for Genomic Medicine, St Mary's Hospital, Manchester, UK. george.burghel@mft.nhs.uk.; Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK. george.burghel@mft.nhs.uk. |
